AG administration dose-dependently reduced the phosphorylation of Smad2 and Smad3 protein in the bleomycin-induced pulmonary fibrosis (p < 0.05, p < 0.01; Figure 4A, D, E). The gene discussed is SMAD2; the disease is pulmonary fibrosis.